SEC Form 4 · accession 0001209191-15-023715
ACORDA THERAPEUTICS INC · ACOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew A. Hindman
Officer — Chief Business Dev. Officer
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001008848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 4, 2015 | A | 4,215 | $0.00 | A | 59,751 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $35.74 | Mar 4, 2015 | A | 23,885 | A | — | Mar 4, 2025 | Common Stock | 23,885 | 23,885 | D |
Explanation of responses
- F1Restricted Shares issued under the Company's 2006 Employee Incentive Plan. The shares will vest 25% every year for four years with vest dates of December 1, 2015, December 1, 2016, December 1, 2017 and December 1, 2018.
- F2The shares subject to this option vest in equal quarterly installments over four years beginning on January 1, 2015 with the first quarterly installment vesting on April 1, 2015.